IDEAYA Biosciences, Inc. SEC filings IDYA
IDEAYA Biosciences, Inc. has 506 filings in SEC EDGAR's recent list, going back to Aug 26, 2016. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 20, 2021 | — |
| CORRESP | Letter to the SEC | Apr 16, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 25, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 23, 2021 | — |
| SEC STAFF LETTER | Filing | Feb 23, 2021 | — |
| EFFECT | Filing | Jun 10, 2020 | — |
| CORRESP | Letter to the SEC | Jun 9, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2020 | — |
| CT ORDER | Filing | May 24, 2019 | — |
| EFFECT | Filing | May 22, 2019 | — |
| CERT | Filing | May 22, 2019 | — |
| CORRESP | Letter to the SEC | May 20, 2019 | — |
| CORRESP | Letter to the SEC | May 20, 2019 | — |
| 8-A12B | Filing | May 17, 2019 | — |
| CORRESP | Letter to the SEC | May 1, 2019 | — |
| DRSLTR | Filing | Apr 15, 2019 | — |
| DRS/A | Filing | Apr 15, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2019 | — |
| DRS/A | Filing | Apr 4, 2019 | — |
| DRSLTR | Filing | Apr 3, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2019 | — |
| DRSLTR | Filing | Mar 15, 2019 | — |
| DRS/A | Filing | Mar 15, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 19, 2019 | — |
| DRS | Filing | Jan 17, 2019 | — |
| D | Filing | May 11, 2018 | — |
| D | Filing | Aug 26, 2016 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IDYA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1676725
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.